Pisarek H, Kunert-Radek J, Radek M, Swietoslawski J, Winczyk K, Pawlikowski M.
Journal Article 2011; 32(1): 96-101 PubMed PMID: 21407161 Keywords: Adenoma:metabolism, Adult, Aged, Biopsy, Female, Gonadotropins, Pituitary:metabolism, Humans, Male, Middle Aged, Neoplasm Recurrence, Local:metabolism, Pituitary Neoplasms:metabolism, Receptors, Somatostatin:metabolism,. CitationOBJECTIVE: Surgical treatment of pituitary macroadenomas often fails because of tumor recurrence after the operation. The causes of tumor .....
Pisarek H, Kunert-Radek J, Radek M, Swietoslawski J, Winczyk K, Pawlikowski M. Expression of somatostatin receptor subtypes in primary and recurrent gonadotropinomas: are somatostatin receptors involved in pituitary adenoma recurrence? Neuro Endocrinol Lett. 2011 Jan; 32(1): 96-101
Winczyk K, Kunert-Radek J, Gruszka A, Radek M, Ławnicka H, Pawlikowski M.
Journal Article 2009; 30(1): 107-110 PubMed PMID: 19300395 Keywords: Acromegaly:etiology, Adenoma:complications, Adrenocorticotropic Hormone:secretion, Adult, Aged, Cell Proliferation:drug effects, Cell Survival:drug effects, Drug Evaluation, Preclinical, Female, Human Growth Hormone:secretion, Humans, Hypoglycemic Agents:. CitationOBJECTIVES: Rosiglitazone (RGZ) belongs to thiazolidinediones - new class of antidiabetic drugs which are PPARgamma agonists. It was shown.....
Winczyk K, Kunert-Radek J, Gruszka A, Radek M, Ławnicka H, Pawlikowski M. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro. Neuro Endocrinol Lett. 2009 Mar; 30(1): 107-110
Pawlikowski M, Kunert-Radek J, Radek M.
Journal Article 2008; 29(3): 347-350 PubMed PMID: 18580839 Keywords: ACTH-Secreting Pituitary Adenoma:metabolism, Adenoma:metabolism, Adrenocorticotropic Hormone:metabolism, Adult, Cushing Syndrome:blood, Female, Humans, Immunohistochemistry, Ki-67 Antigen:blood, Male, Nelson Syndrome:blood, Paraffin Embedding, Pituitary H. CitationOBJECTIVES: The aim of the study was to evaluate the ACTH-immunopositive pituitary adenomas, especially those without manifestation of Cus.....
Pawlikowski M, Kunert-Radek J, Radek M. "Silent"corticotropinoma. Neuro Endocrinol Lett. 2008 Jun; 29(3): 347-350
Ławnicka H, Pisarek H, Kunert-Radek J, Pawlikowski M.
Journal Article 2008; 29(1): 113-116 PubMed PMID: 18283262 Keywords: Adenoma:metabolism, Adult, Aged, Female, Growth Hormone:metabolism, Hemangiopericytoma:metabolism, Humans, Male, Middle Aged, Pituitary Neoplasms:metabolism, Prolactin:metabolism, Receptors, Somatostatin:metabolism, Somatostatin:pharmacology, Tumor Cells,. CitationOBJECTIVES: The aim of the study was to examine the effect of somatostatin (SST) on vascular endothelial growth factor (VEGF) secretion fr.....
Ławnicka H, Pisarek H, Kunert-Radek J, Pawlikowski M. Effects of somatostatin on vascular endothelial growth factor (VEGF) secretion from non-functioning pituitary tumoral cells incubated in vitro. Neuro Endocrinol Lett. 2008 Feb; 29(1): 113-116
Winczyk K, Lawnicka H, Pawlikowski M, Kunert-Radek J, Karasek M.
Comparative Study 2006; 27(3): 351-354 PubMed PMID: 16816834 Keywords: Adenocarcinoma:drug therapy, Animals, Antimetabolites, Antineoplastic:pharmacology, Antineoplastic Agents, Hormonal:pharmacology, Antineoplastic Combined Chemotherapy Protocols:pharmacology, Breast Neoplasms:drug therapy, Cell Line, Tumor, Cell Proliferat. CitationOBJECTIVES: Melatonin may influence directly tumor cells through the specific binding sites. The best known melatonin binding sites are me.....
Winczyk K, Lawnicka H, Pawlikowski M, Kunert-Radek J, Karasek M. Growth-inhibitory action of melatonin and thiazolidinedione derivative CGP 52608 on murine 16/C breast cancer cells. Neuro Endocrinol Lett. 2006 Jun; 27(3): 351-354
OBJECTIVES: The process of neoangiogenesis plays a key role in development and progression of solid tumours. The formation of new blood ve.....
Ławnicka H, Kunert-Radek J. Stimulatory effect of GH3 cell line conditioned medium on the proliferation of the endothelial cell line (HECa10) in vitro. Neuro Endocrinol Lett. 2005 Aug; 26(4): 413-418